$110-180k
Plus equity
Developing software as prescription treatments
Job no longer available
Developing software as prescription treatments
101-200 employees
Job no longer available
$110-180k
Plus equity
101-200 employees
To deliver safe and effective digital treatments to patients in need.
Jump to section
To deliver safe and effective digital treatments to patients in need.
Prescription medical treatments have historically been comprised only of pharmaceutical drugs and therapies, but digital therapeutics present an effective and low-cost alternative. With treatment provided through a clinically trialled app, these solutions have found success in tackling major medical issues such as type 2 diabetes, depression and and smoking.
Click Therapeutics is one company working in this field, providing prescription software as a treatment for patients with unmet and high-burden needs such as chronic pain, major depressive disorder and migraines. There are other companies working in this area such as OurPath, Soma, and Ieso, but the global digital therapeutics market is estimated to be worth up to $18 billion by 2027 and is still largely untapped, leaving plenty of room to grow.
Click Therapeutics has raised funding through several investment rounds and debt financing. It is using this capital to accelerate the development of its products and further improve the performance of its platform. As the efficacy of digital therapeutics becomes more widely-known, Click Therapeutics is in a strong position to grow.
Freddie
Company Specialist
Oct 2021
$52m
SERIES B
Oct 2018
$19m
EARLY VC
Founders
David Benshoof Klein
(CEO)Experience as Managing Director of Opus Point Partners from 2007 to 2012. Senior Consultant of Pfizer from 2012 to 2014.
Jobs (3)
Software Engineering
Operations & Strategy